GenOptimiser
Deep disease mechanics and network pharmacology.
Decodes relationships between gene expression and multi-omic disease networks to uncover true contextual causality rather than simple correlation.
Platform
The ultimate computational blueprint for asset longevity and de-risking

NEXUS-Rx engine
Platform architecture
Core modules are fully integrated into the platform suite, yet commercialized separately as standalone software solutions to match your pipeline's exact needs.
Deep disease mechanics and network pharmacology.
Decodes relationships between gene expression and multi-omic disease networks to uncover true contextual causality rather than simple correlation.
Preclinical animal model validation and translation.
Evaluates how effectively animal models mimic human pathology, explicitly bridging cellular network information to clinical features to catch translational blind spots.
Trial repository data intelligence and outcome engineering.
Applies deep learning and RAG models to optimize patient populations, endpoint parameters, and inclusion criteria—minimizing trial failures and avoiding costly protocol amendments.
Target combinations and therapeutic repositioning.
Leverages a semi-manually enriched internal database to screen complex target combinations and uncover novel dual-action therapeutic pathways.
BD and licensing workflow
Drop your scientific queries or evidence gaps into the interface to instantly coordinate parallel sub-tasks and eliminate manual search string generation. NEXUS-Rx maps your inquiry into an open, reviewable knowledge graph instead of an uninterpretable AI summary.
Trigger deep semantic sweeps across multi-omic layers and full-text literature to isolate high-fidelity data trends and build evidence-backed hypotheses. The engine frames exactly why a biological relationship matters while exposing past scientific dead ends.
Run machine learning comparisons and evidence grading directly on mapped biological networks. The system immediately strips out noise, flags weak data, and surfaces cross-species phenotypic contradictions to catch vulnerabilities early.
Converge filtered insights into publication-grade network maps and audit-ready strategic briefs. Built for corporate licensing teams to compare evidence paths and prepare sharp diligence questions compressing multi-week partner evaluations into mere hours.
Full internal discovery engine integration, enterprise-wide suite deployment, or individual standalone modules (GenOptimiser, PhenoLink, ClinForecast).
100% EU-designed and hosted; engineered by biophysicists and ML researchers to be completely verifiable, traceable, and auditable.
Flexible Annual Platform Subscriptions per module, full institutional ecosystem licensing managed through MedInsights and contract research agreements (CRA).